abstract |
The present disclosure is a method of treating medulloblastoma in a subject in need of treatment for medulloblastoma, comprising administering to the subject a therapeutically effective amount of an enhancer (EZH2) inhibitor of zest homolog 2 Provide a method. In a preferred embodiment of the method, the subject is a child and the EZH2 inhibitor is tazemethostat. |